Three Genes May Help Distinguish RA From OA
-
By
-
Andrea Surnit
-
April 22, 2026
-
3 min
By
Andrea Surnit
April 22, 2026
Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients
May 11, 2026
Meta-analysis favored tofacitinib for some rheumatoid arthritis outcomes, but high heterogeneity, dose-dependent effects, and JAK inhibitor safety concerns complicate interpretation.
May 8, 2026
Patients with chronic lung disease had numerically lower remission rates and substantially more serious adverse events in a 5-year Japanese registry study of late-onset rheumatoid arthritis.
May 8, 2026